Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells
about
Application of epigenome-modifying small molecules in induced pluripotent stem cells.High-throughput sequencing reveals the disruption of methylation of imprinted gene in induced pluripotent stem cellsTranscriptome Signature and Regulation in Human Somatic Cell Reprogramming.Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cellsMixl1 and Flk1 Are Key Players of Wnt/TGF-β Signaling During DMSO-Induced Mesodermal Specification in P19 cells.Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming.Reprogramming cancer cells: back to the future.A signature for induced pluripotent stem cell-associated genes in colorectal cancer.Loss of the RNA helicase SKIV2L2 impairs mitotic progression and replication-dependent histone mRNA turnover in murine cell lines.Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.Soft Tissue Sarcoma Cancer Stem Cells: An OverviewIdentification of protein kinase inhibitors to reprogram breast cancer cellsReprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors
P2860
Q34031951-37A71A49-F0B5-48A2-9A9D-F1FE9FFB0E96Q35079288-E6BEDC16-091E-47D4-AD02-A9156B20D447Q35754369-2D61EEEA-7827-4630-8AA3-DF2EA19E488FQ36686899-6F559D3E-C0B6-41C0-8C20-631695E0F408Q38927381-7383454C-54AB-48F6-BA10-52D8C2A3FE01Q39317413-D69B7527-FC3B-4EEC-BB46-476F7EFC307FQ39573471-C3127A8D-DC8C-4FB1-904C-36A5347AC1B4Q44796456-8A185AC8-8879-48DD-A4C6-FC74DADB0834Q51082530-7DDA7A2B-58AA-41ED-BEBD-B4C6052FED21Q53182297-D49EFDCC-49BB-42B3-972E-1D780940F603Q58707604-345BABF2-F584-4A80-B97F-0692F7A23301Q58751979-B5CB0C24-4B1E-4BC0-9C12-578C2C4C5499Q58803096-E59A7493-CDF9-46B9-B8DA-9C672F161B16
P2860
Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Linking incomplete reprogrammi ...... derived pluripotent stem cells
@ast
Linking incomplete reprogrammi ...... derived pluripotent stem cells
@en
Linking incomplete reprogrammi ...... erived pluripotent stem cells.
@nl
type
label
Linking incomplete reprogrammi ...... derived pluripotent stem cells
@ast
Linking incomplete reprogrammi ...... derived pluripotent stem cells
@en
Linking incomplete reprogrammi ...... erived pluripotent stem cells.
@nl
prefLabel
Linking incomplete reprogrammi ...... derived pluripotent stem cells
@ast
Linking incomplete reprogrammi ...... derived pluripotent stem cells
@en
Linking incomplete reprogrammi ...... erived pluripotent stem cells.
@nl
P2093
P2860
P1433
P1476
Linking incomplete reprogrammi ...... derived pluripotent stem cells
@en
P2093
Da-Yuan Chen
Gang Chang
Qing-Yuan Sun
Shaorong Gao
Yi-Liang Miao
Zhaohui Kou
P2860
P304
P356
10.1371/JOURNAL.PONE.0010320
P407
P50
P577
2010-04-26T00:00:00Z